Constellation Healthcare Technologies Inc (LSE:CHT) - Overview

Stock Report

Constellation Healthcare Technologies Inc CHT

Last Price
GBX215.50

Day Change
-1.00|-0.46%

As of 02/12/2016
17:15:05 GMT | GBX
Minimum 15 Minutes Delay.

Last Close216.50p
Day Range213.00 - 214.00
Mkt Cap197.80Mil
52-Wk Range126.00 - 257.00
Yield %0.86
ISINUSU210051004
Volume22,500
P/E29.93
P/S2.62
P/CF12.96

Share Price

Total Returns 01/12/2016

 Chg (%)  
More ...
Constellation Healthcare Technologies Inc13.95 
FTSE 100 TR GBP-1.92
 
Financials
201320142015
More ...
Income Statement
Turnover33.3933.1750.23
Operating Profit2.016.6712.57
Net Profit-0.541.004.56
Reported EPS-0.9827.337.20
Balance Sheet
Current Assets7.0218.1912.95
Non Current Assets20.6524.4660.41
Total Assets27.6842.6573.36
Current Liabilities4.457.3212.32
Total Liabilities16.0720.8032.03
Total Equity11.6121.8541.33
Cash Flow
Operating Cash Flow3.164.8910.16
Net Change in Cash2.088.57-10.22
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
--------
--------
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
25/11/2016SaleMr. Paul Parmar0.0017,862,0740.00
25/11/2016SaleMr. Paul Parmar0.006,993,5630.00
25/11/2016SaleMr. Paul Parmar0.002,962,8040.00
25/11/2016PurchaseMr. Paul Parmar0.0024,855,6370.00

Company Profile

Constellation Healthcare Technologies Inc provides outsourced business services to physicians, serving the physician market. The Company's business segments are Revenue Cycle Management, Practice Management and Group Purchasing Organization.
 

Sector

Business Services

Market Position

682 of 1866 Companies

Index

Outlook

(02/09/2016) "...we will meet the markets guidance on revenue as well as profits for the full year 2016"

Next Event 31/12/2016

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)0.0017.0616.37
Div Yld (E)0.002.034.37
PEG (E)0.001.47-0.06
ROCE120.9033.3180.94
Op Mrgn19.56-26.67-14.75
EPS Grwth0.0015.7325.31
Dividends
PreviousLatest
More ...
Record Datet.b.c.24/04/15
Ex-Divt.b.c.23/04/15
Paidt.b.c.08/06/15
Amnt0.001.86

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. John Johnston
Chief Executive OfficerMr. Paul Parmar
Chief Financial OfficerMr. Sam Zaharis
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.